115 related articles for article (PubMed ID: 10800611)
1. Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma.
Kawamura K; Kobayashi Y; Tanaka T; Ikeda R; Fujikawa-Yamamoto K; Suzuki K
Anal Quant Cytol Histol; 2000 Apr; 22(2):107-13. PubMed ID: 10800611
[TBL] [Abstract][Full Text] [Related]
2. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
3. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
6. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
[TBL] [Abstract][Full Text] [Related]
10. Quantitative DNA analysis in renal cell carcinoma. Comparison of flow and image cytometry.
Papadopoulos I; Weichert-Jacobsen K; Nürnberg N; Sprenger E
Anal Quant Cytol Histol; 1995 Aug; 17(4):272-5. PubMed ID: 8526952
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of flow-cytometry and immunohistochemistry with proliferating monoclonal antibody. Cell nuclear antigen (PCNA) in the study of proliferative kinetics of renal carcinoma].
Villari D; Iannelli F; Li Marzi V; Marzocco M; Amorosi A; Trippitelli A; Nicita G
Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():33-7. PubMed ID: 9181920
[TBL] [Abstract][Full Text] [Related]
12. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
14. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
15. DNA cytometry in renal cell carcinoma.
Nenning H; Rassler J; Minh DH
Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
[TBL] [Abstract][Full Text] [Related]
16. DNA and PCNA content of renal cell carcinoma and prognosis.
Flint A; Grossman HB; Liebert M; Lloyd RV; Bromberg J
Am J Clin Pathol; 1995 Jan; 103(1):14-9. PubMed ID: 7817936
[TBL] [Abstract][Full Text] [Related]
17. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation].
Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
19. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
[TBL] [Abstract][Full Text] [Related]
20. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
